Janet Snell-Bergeon

23PUBLICATIONS
47CO-AUTHORS
Behavioural epidemiologyPharmacogenomicsSolid tumoursRural community developmentModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 01, 2026
Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST-T1D Extension Study.

|Dec 22, 2025
Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis.

Kagan E Karakus, Halis K Akturk, Davida Kruger

|Mar 18, 2025
Cardiovascular and Renal Biomarkers in Overweight and Obese Adults with Type 1 Diabetes Treated with Tirzepatide for 21 Months.

Satish K Garg, Gurleen Kaur, Drew Renner

|Feb 14, 2025
Progression of Diabetic Retinopathy After Initiation of Automated Insulin Delivery System in Adults With Type 1 Diabetes.

Kagan E Karakus, Halis K Akturk, Janet K Snell-Bergeon

|Feb 13, 2025
Case series of a hybrid closed loop therapy system used in pregnancy.

Trinity L Brigham, Matthew P Klein, Janet K Snell-Bergeon

|Jan 02, 2025
Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes.

Janet K Snell-Bergeon, Gurleen Kaur, Drew Renner

Pageof 4

Frequent Collaborators

9 joint publications

Halis Kaan Akturk

6 joint publications

Viral N Shah

4 joint publications

Matthew P Klein

3 joint publications

Kagan E Karakus